AbbVie Inc. is a large biopharmaceutical company that researches, develops, and sells prescription medicines. It lobbies on patent and intellectual property rules, drug pricing and Medicare Part D policies, and tax and labor issues that affect its business. Recent filings show it has engaged directly on specific bills about patent litigation, drug copays, patient access to complex therapies, and implementing the drug negotiation rules in the Inflation Reduction Act.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CRYSTAL RILEY
The latest disclosures for this client.
ABBVIE, INC.
Q1ABBVIE, INC.
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
ABBVIE, INC.
DANIEL BACHNER
ABBVIE, INC.
DORCAS ADEKUNLE
ABBVIE, INC.
RACHEL DERBY
ABBVIE, INC.
STEPHEN SCANGO
ABBVIE, INC.
ABBVIE, INC.
Q3ABBVIE, INC.
Q2ABBVIE, INC.
Q1